These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 4263768)
41. [Basis, clinical picture and therapy of diseases of the extrapyramidal-motoric system (EPMS)]. Völler GW; Deze J Z Allgemeinmed; 1975 Mar; 51(8):353-73. PubMed ID: 1094755 [No Abstract] [Full Text] [Related]
42. [Differential diagnosis of essential tremor]. Ivanova-Smolenskaia IA Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(3):321-6. PubMed ID: 7257671 [No Abstract] [Full Text] [Related]
43. Electrophysiological targeting in stereotaxic surgery for Parkinson's disease. Macias R; Teijeiro J; Torres A; Alvarez L Adv Neurol; 1997; 74():175-82. PubMed ID: 9348413 [No Abstract] [Full Text] [Related]
44. The pharmacology of extrapyramidal movement disorders. Klawans HL Monogr Neural Sci; 1973; 2():1-136. PubMed ID: 4271860 [No Abstract] [Full Text] [Related]
46. [Clinical experience in conray ventriculography]. Sakamoto S; Shirao T; Okuma Y; Ando M Rinsho Hoshasen; 1971 Oct; 16(10):863-8. PubMed ID: 5316976 [No Abstract] [Full Text] [Related]
47. Putamenotomy as an aid to upper extremity control. Heimburger RF Confin Neurol; 1975; 37(1-3):16-23. PubMed ID: 124239 [No Abstract] [Full Text] [Related]
48. [Indications for stereotaxic thalamotomy. Part 1: Extrapyramidal symptoms (author's transl)]. Narabayashi H No Shinkei Geka; 1976 Apr; 4(4):329-35. PubMed ID: 131913 [No Abstract] [Full Text] [Related]
49. [Severe reactions caused by Conray-400 used in ventriculography and myelography]. Li ZX Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1982 Sep; 15(3):141-2. PubMed ID: 6983954 [No Abstract] [Full Text] [Related]
50. Physiological observations during stereotactic surgery of the basal ganglia. Fairman D; Perlmutter I Confin Neurol; 1965; 26(3):298-305. PubMed ID: 5329832 [No Abstract] [Full Text] [Related]
51. A stereotaxic instrument for pallidothalamectomy in Parkinson's disease. RAND RW J Neurosurg; 1961 Mar; 18():258-60. PubMed ID: 13739434 [No Abstract] [Full Text] [Related]
52. Surgery for Parkinson's disease, the five W's: why, who, what, where, and when. Lozano AM Adv Neurol; 2003; 91():303-7. PubMed ID: 12442688 [No Abstract] [Full Text] [Related]
53. ANESTHETIC MANAGEMENT FOR BASAL GANGLIA SURGERY IN PATIENTS WITH MOVEMENT DISORDERS. STEEN SN Anesth Analg; 1965; 44():66-9. PubMed ID: 14264817 [No Abstract] [Full Text] [Related]
54. The placement of stereotaxic lesions for involuntary movements other than in Parkinson's disease. Andrew J; Edwards JM; Rudolf Nde M Acta Neurochir (Wien); 1974; Suppl 21():39-47. PubMed ID: 4278333 [No Abstract] [Full Text] [Related]
55. Clinical study and results of stereoencephalotomy in the treatment of Parkinsonism. Donoso P; Rocamora R; Chiorino R; Flandes B; Asenjo A; Aranda L Neurocirugia; 1965; 23(1):109-11. PubMed ID: 5338768 [No Abstract] [Full Text] [Related]
56. Experience with stereotactics for dystonia: case examples. Iacono RP; Kuniyoshi SM; Schoonenberg T Adv Neurol; 1998; 78():221-6. PubMed ID: 9750918 [No Abstract] [Full Text] [Related]
57. Biochemistry of the basal ganglia. Fahn S Adv Neurol; 1976; 14():59-89. PubMed ID: 7932 [No Abstract] [Full Text] [Related]
58. Dentatectomy in the treatment of dyskinetic disorders. Heimburger RF Confin Neurol; 1967; 29(2):101-6. PubMed ID: 4231821 [No Abstract] [Full Text] [Related]
59. [Newer indications for stereotaxic operations]. Riechert T Z Allgemeinmed; 1973 Feb; 49(6):253-6. PubMed ID: 4576196 [No Abstract] [Full Text] [Related]
60. Stereotaxic surgery in a community hospital. Zazanis GA; Liss HR Confin Neurol; 1969; 31(1):129-34. PubMed ID: 4900484 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]